The Patent Finder

Universite d'Angers

10 patents currently held · Updated Nov 16, 2026
18 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 6 name spellings.

0
Ending by 2030
Oct 2031
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 10, 2027
    The maintenance fee for Potentiating agents for protecting plants from fungal infections (US 10,405,550) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
  • 1 fee due Jun 3, 2027
    The maintenance fee for Tocotrienol derivatives, pharmaceutical composition and method of use in 5-lipoxygenase related diseases (US 10,494,357) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 10,861,582Non-Invasive Method for Assessing Liver Fibrosis Progression
In force
 · High confidence
In forceHigh confidence
US 10,123,976Dispersion of Poloxamer- Protein Particles, Methods of Manufacturing and Uses Thereof
In force
 · High confidence
In forceHigh confidence
US 10,405,550Potentiating agents for protecting plants from fungal infections
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,566,260Potentiating Agents for Protecting Plants from Fungal Infections
In force
 · Low confidence
In forceLow confidence
US 10,165,987Method for Displaying Medical Images
In force
 · High confidence
In forceHigh confidence
US 10,494,357Tocotrienol derivatives, pharmaceutical composition and method of use in 5-lipoxygenase related diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,858,306Method for Synthesizing Iodo- or Astatoarenes Using Diaryliodonium Salts
In force
 · High confidence
In forceHigh confidence
US 11,605,460Multi-Targeted Fibrosis Tests
In force
 · High confidence
In forceHigh confidence
US 12,617,831Peptide Targeting Gip and GLP-2 Receptors for Treating Bone Disorders
In force
 · High confidence
In forceHigh confidence
US 12,637,660Small Extracellular Vesicles Expressing a Dominant Negative Ampk Alpha 1 Mutant for Use in the Treatment of Obesity
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 18 patents in force now held by others · 29 lapsed for an unpaid fee · 4 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 29 abandoned · 8 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited